GLENDALE, Ariz. – Derek Anderson raised his voice and his eyes bulged wide. Looking directly at a reporter in the crowd, the Arizona Cardinals' quarterback let loose.
NEW YORK (Reuters) – Comcast Corp and Level 3 Communications, a key network partner of Netflix Inc, launched into a vicious public battle over fees Comcast is levying at Level 3 for delivering content such as movies to the cable company's customers.
LOS ANGELES – Allen Haff has found himself in a precarious position. Armed with a pocket knife and a rechargeable flashlight resembling a space-age ray gun, the lanky 41-year-old is dangerously perched inside a storage unit on the side of a mattress that is teetering against a rickety tower of boxes.
PARIS (AFP) – A 71-year-old retired electrician is at the centre of a legal battle after coming forward with more than 200 hitherto unknown paintings by Pablo Picasso, a French newspaper reported Monday.
WASHINGTON – A leading Republican lawmaker on Sunday rejected the Obama administration's assertion that ratification of a new arms control treaty with Russia is so pressing that it must be dealt with by the lame-duck Senate.
CAIRO (Reuters) – Opposition charges of ballot stuffing, bullying and dirty tricks clouded a parliamentary election in Egypt on Sunday in which the ruling party wants to prevent its Islamist rivals from repeating their 2005 success.
MEXICO CITY (Reuters) – Diego Fernandez de Cevallos, a prominent Mexican politician and former presidential candidate who was kidnapped in May, has been released, daily El Universal reported on Saturday.
LONDON (AFP) – Formula One boss Bernie Ecclestone told how he had been knocked to the floor and kicked unconscious by a gang of muggers who attacked the diminutive 80-year-old in London, a newspaper reported Saturday.
CANBERRA, Australia – The Australian Senate on Friday approved legislation that enables the government to roll out a 36 billion Australian dollar ($35 billion) high-speed national broadband network.
ZURICH (Reuters) – Relations have turned icy between the CEOs of Roche and Novartis as Switzerland's top two drug executives defend their very different strategies to making money in a tough healthcare market.